Police checking vehicle on the high way is illegal - AIG

Any policeman checking vehicle particulars is on illegal duty – AIG

Read more at: http://www.vanguardngr.com/2016/10/policeman-checking-vehicle-particulars-illegal-duty-aig/

Fani-Kayode's odeal with EFCC continues

Fani-Kayode alleged on Thursday, 18th October 2016  that the anti corruption body is planning his arrest and a reliable source from EFCC camp inform him about a premeditated plan to keep him in detention indefinitely.  

His perception became a reality as he was arrested the following day

Biotech firm to develop 3D bioprinted liver tissue for direct transplantation to patients

Organovo is announcing its program to develop 3D bioprinted human liver tissue based on the achievement of strong results in preclinical studies that used animal models. These demonstrated engraftment, vascularisation and sustained functionality of bioprinted liver tissue, including stable detection of liver-specific proteins and metabolic enzymes. The company expects to pursue this opportunity with a formal preclinical development program.
For patients in need of a liver transplant, no robust alternatives exist today. Approximately 17,000 patients are on the U.S. liver transplant waiting list, but only 6,000 liver transplants are performed each year.
Organovo plans to develop clinical solutions in two initial areas. First, acute-on-chronic liver failure (ACLF) is a recognised and distinct orphan disease entity encompassing an acute deterioration of liver function in patients with liver disease, which affects 150,000 patients annually in the United States. Second, paediatric metabolic liver diseases are another orphan disease indication where a bioprinted liver tissue patch may show therapeutic benefits.
The total addressable market opportunity for these initial indication areas exceeds $3 billion. Assuming development progresses according to its plan, Organovo intends to submit an Investigational New Drug application to the U.S. Food and Drug Administration (FDA) for its therapeutic liver tissue in three to five years. Organovo will seek breakthrough therapy designation, clinical development outside the United States, and other opportunities to help accelerate time to market. The company will also present more detailed preclinical results at upcoming scientific conferences.

End of an Era: Gulfstream To Cease G450 Production in 2018

Gulfstream Aerospace announced on October 21 that it will cease production of the G450 as it prepares for service entry of its new fly-by-wire G500 in early 2018, the same time it is scheduled to deliver the final G450. This provides a seamless product transition between the two business jets.
The G450 was built on the success of the GIV and GIV-SP, which themselves were derived from the GIII and GII twinjets, as well as the GI turboprop twin. The GIV first flew on Sept. 19, 1985, and entered service in August 1987. Gulfstream produced more than 870 GIVs, GIV-SPs and G450s over the past 29 years. The GIV family also was the foundation for the ultra-long-range GV series.
“The GIV and G450 ushered in a business aviation renaissance that has led to increased safety, greater reliability, better technology and improved performance,” said Gulfstream president Mark Burns. “It’s fitting that the G500 will replace the G450 and build upon its performance legacy, creating another industry game-changer from Gulfstream.”
Powered by a pair of Pratt & Whitney Canada PW814GAs, the 5,000-nm G500 features Gulfstream’s Symmetry Flight Deck and a fly-by-wire system with active control sidesticks. Five G500s are currently in flight testing, with FAA certification expected next year. To date, the flight-test program has amassed more than 1,600 flight hours. In addition, a G500 simulator is already in use at FlightSafety International in Savannah, Georgia.

Where was this kind of comedy last night? Hillary Clinton reacts to Trumpt's twit

According to Trump, The results are in on the final debate and it is almost unanimous, I WON! Thank you, these are very exciting times. And immediately, Hillary Clinton fired back through her twitter handle by saying Where was this kind of comedy last night?

Bishop David Abioye on Evangelism

Bishop David Abioye of Living Faith Church also known as Winners Chapel uploaded a picture of his outreaches to people through evangelism via his facebook page. Only few men of God who have grown big in ministry could still do this type of evangelism.